Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

908 Devices Announces Significant Milestones

Published: Wednesday, August 20, 2014
Last Updated: Wednesday, August 20, 2014
Bookmark and Share
Company has expanded its office from a 7,000 square-foot R&D think tank into a 16,000 square-foot full-scale production facility.

908 Devices announced a number of significant milestones since the introduction of its flagship product, M908™, the world’s first and only handheld tool utilizing high-pressure mass spectrometry™ (HPMS) for trace-level chemical detection and identification.

The company's facility is strategically located in Boston’s Innovation District on DryDock Avenue –  an area undergoing radical transformation, attracting Boston’s most creative firms and tech companies.  The new space includes a full machine shop, analytical and R&D labs, clean room, and collaborative meeting areas,  allowing the team to create new concepts, prototypes, and manufacture product in-house, all under one roof.  The expansion to a full production facility also provides the company with flexibility as it continues to grow and penetrate new markets. By designing and manufacturing products in-house, the team will stay actively involved in every stage of development, design verification, and manufacturing quality.

Since unveiling the powerful capabilities of HPMS in March 2014 with the introduction of M908, 908 Devices has recognized significant company momentum, which includes:

• Joe Griffith being appointed Chief Financial Officer, bringing his 17-year management background in corporate and operational finance, accounting and administration to 908 Devices. Joe previously served as CFO for PerkinElmer’s Life Science & Technology division and as CAO for Caliper Life Sciences.

• Expansion to 908 Device’s science and engineering staff to ramp up product development efforts for energy, environmental, and life science markets.

• To fuel the companies continued growth, the team has increased from its seven initial founders in 2012 to 30+ employees today with an expected 50% increase in 2015.

• The company is a recipient of the Mass Life Sciences Center award, providing up to $25 million in tax incentives for companies who are committed to creating new jobs in the Commonwealth and those who currently engaged in life sciences research and development.

“2014 is a banner year for 908 Devices, marked with tremendous growth and success,” said Dr. Kevin J. Knopp, co-founder and CEO, 908 Devices. “Within the analytical instrumentation industry, there has been an incredible shift in demand from very complex catch-all laboratory systems to purpose-built and user-centric analytical tools. The momentum of M908 demonstrates that we are meeting this need and we will continue to focus on delivering the best-in-class devices and solutions for our safety and security customers to use in the field.  In addition, we see a lot of opportunity to expand our HPMS platform technology into exciting new applications, including energy, environmental monitoring, and life sciences.  We are very fortunate to have been able to assemble some incredible talent to bring the most impactful technology out-of-the-lab in order to deliver meaningful results and create simplified tools out of mass spectrometry for these industries.”

“This is an exciting time to be joining 908 Devices,” said Joe Griffith, CFO, 908 Devices. “The success of M908 combined with the recent expansion to a full-scale production facility demonstrates that 908 Devices is poised to make a huge impact on mass spectrometry in the safety and security market and beyond. This is one of the most talented, forward thinking teams in the industry and I believe I can only help to propel the company forward as we build out infrastructure and processes to support our growth and strategic initiatives. I am honored to be joining the team and look forward to contributing to the company’s continued success.”

An interview with 908 Devices' VP and CTO, Dr. Christopher D. Brown, can be found on LabTube.tv.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

908 Devices Receives $7 Million in Series B Funding
The financing round will be used to expand the R&D team and to accelerate and commercialize 908 Devices’ initial safety and security products.
Wednesday, September 11, 2013
908 Devices’ Research Partner Presents Research on Mass Spectrometry
Advancing the rapidly evolving field of High Pressure Mass Spectrometry.
Friday, August 16, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!